Literature DB >> 31391798

Update on Pregnancy in Patients With Inflammatory Bowel Disease.

Anita Afzali1.   

Abstract

Entities:  

Year:  2019        PMID: 31391798      PMCID: PMC6676357     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN: 1554-7914


× No keyword cloud information.
  5 in total

1.  Exposure Concentrations of Infants Breastfed by Women Receiving Biologic Therapies for Inflammatory Bowel Diseases and Effects of Breastfeeding on Infections and Development.

Authors:  Rebecca Matro; Christopher F Martin; Douglas Wolf; Samir A Shah; Uma Mahadevan
Journal:  Gastroenterology       Date:  2018-05-30       Impact factor: 22.682

2.  Pregnancy Outcomes Reported During the 13-Year TREAT Registry: A Descriptive Report.

Authors:  Gary R Lichtenstein; Brian G Feagan; Uma Mahadevan; Bruce A Salzberg; Wayne Langholff; James G Morgan; Michael Safdi; Riikka Nissinen; François Taillard; William J Sandborn; Russell D Cohen
Journal:  Am J Gastroenterol       Date:  2018-07-19       Impact factor: 10.864

3.  Inflammatory bowel disease during pregnancy: management of a disease flare or remission.

Authors:  Anita Afzali
Journal:  Curr Opin Gastroenterol       Date:  2019-07       Impact factor: 3.287

4.  Outcomes of Pregnancies With Maternal/Paternal Exposure in the Tofacitinib Safety Databases for Ulcerative Colitis.

Authors:  Uma Mahadevan; Marla C Dubinsky; Chinyu Su; Nervin Lawendy; Thomas V Jones; Amy Marren; Haiying Zhang; Daniela Graham; Megan E B Clowse; Steven R Feldman; Daniel C Baumgart
Journal:  Inflamm Bowel Dis       Date:  2018-11-29       Impact factor: 5.325

5.  Pregnancy Outcomes After Exposure to Certolizumab Pegol: Updated Results From a Pharmacovigilance Safety Database.

Authors:  Megan E B Clowse; Angela E Scheuerle; Christina Chambers; Anita Afzali; Alexa B Kimball; John J Cush; Maureen Cooney; Laura Shaughnessy; Mark Vanderkelen; Frauke Förger
Journal:  Arthritis Rheumatol       Date:  2018-07-22       Impact factor: 10.995

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.